Congenital mesoblastic nephroma. Own experience of the Research Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia

Congenital mesoblastic nephroma (CMN) is a rare primary kidney tumor in young children, characterized by intermediate biological behavior. The main treatment method is the radical removal of the tumor. The purpose of this study is to analyze our own experience in the treatment of patients with a diagnosis of CMN. Parents of patients agreed to the use of information about them, including photographs, in scientific research and publications.

1. Pastore G., Znaor A., Spreafico F., Graf N., Pritchard-Jones K., Steliarova-Foucher E. Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):2103-14. doi: m.1016/j.ejca.2006.05.010.

2. Vujanic G.M., Sandstedt B. The pathology of Wilms tumor (nephroblastoma): the international Society of Paediatric Oncology approach. J Clin Pathol 2010;63(2):102-9. doi: 10.1136/jcp.2009.064600.

3. Reinhard H., Semler O., Burger D., Bode U., Flentje M., Gobel U., Gutjahr P., Leuschner I., Maass E., Niggli F., Scheel-Walter H.G., Stockle M., Thuroff J.W., Troger J., Weirich A., von Schweinitz D., Zoubek A., Graf N. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Padiatr 2004;216(3):132-40. doi: 10.1055/s-2004-822625.

4. Pettinato G., Manivel J.C., Wick M.R., Dehner L.P. Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. Hum Pathol 1989;20(7):682-90. doi: 10.1016/0046-8177(89)90156-1.

5. Furtwaengler R., Reinhard H., Leuschner I., Schenk J.P., Goebel U., Claviez A., Kulozik A., Zoubek A., von Schweinitz D., Graf N.; Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) Nephroblastoma Study Group. Mesoblastic nephroma - a report from the Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH). Cancer 2006;106(10):2275-83. doi: 10.1002/cncr.21836.

6. Watanabe N., Haruta M., Soejima H., Fukushi D., Yokomori K., Nakadate H., Okita H., Hata J.I., Fukuzawa M., Kaneko Y. Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type. Genes Chromosomes Cancer 2007;46(10):929-35. doi: 10.1002/gcc.20481.

7. Bolande R.P., Brough A.J., Izant R.J. Jr. Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms’ tumor. Pediatrics 1967;40(2):272-8. PMID: 4378178.

8. Anderson J., Gibson S., Sebire N.J. Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma. Histopathology 2006;48(6):748-53. doi: 10.1111/j.1365-2559.2006.02400.x.

9. Gooskens S.L., Houwing M.E., Vujanic G.M., Dome J.S., Diertens T., Coulomb-l’Hermine A., Godzinski J., Pritchard-Jones K., Graf N., van den Heuvel-Eibrink M.M. Congenital mesoblastic nephroma 50 years after its recognition: A narrative review. Pediatr Blood Cancer 2017;64(7). doi: 10.1002/pbc.26437.

10. Dal Cin P, Lipcsei G., Hermand G., Boniver J., Van den Berghe H. Congenital mesoblastic nephroma and trisomy 11. Cancer Genet Cytogenet 1998;103(1):68-70. doi: 10.1016/s0165-4608(97)00350-6.

11. Speleman F., Van Den Berg E., Dhooge C., Osterhuis W., Redeker B., De Potter C.R., Tamminga R.Y., Van Roy N., Mannens M. Cytogenetic and molecular analysis of cellular atypical mesoblastic nephroma. Genes Chromosomes Cancer 1998;21(3):265-9. doi: 10.1002/(sici)1098-2264(199803)21:3<265::aid-gcc13>3.0.co;2-o.

12. Knezevich S.R., Garnett M.J., Pysher T.J., Beckwith J.B., Grundy P.E., Sorensen P.H. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 1998;58(22):5046-8. PMID: 9823307.

13. Wegert J., Vokuhl C., Collord G., Del Castillo Velasco-Herrera M., Farndon S.J., Guzzo C., Jorgensen M., Anderson J., Slater O., Duncan C., Bausenwein S., Streitenberger H., Ziegler B., Furtwangler R., Graf N., Stratton M.R., Campbell P.J., Jones D.T., Koelsche C., Pfister S.M., Mifsud W., Sebire N., Sparber-Sauer M., Koscielniak E., Rosenwald A., Gessler M., Behjati S. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun 2018;9(1):2378. doi: 10.1038/s41467-018-04650-6.

14. Sutherland R.W., Wiener J.S., Hicks M.J., Hawkins E.P, Chintagumpala M. Congenital mesoblastic nephroma in a child with the Beckwith-Wiedemann syndrome. J Urol 1997;158(4):1532-3. PMID: 9302166.

15. Fuchs I.B., Henrich W., Brauer M., Stover B., Guschmann M., Degenhardt P., Dudenhausen J.W. Prenatal diagnosis of congenital mesoblastic nephroma in 2 siblings. J Ultrasound Med 2003;22(8):823-7. doi: 10.7863/jum.2003.22.8.823.

16. Whittle S., Gosain A., Brown P.Y., Debelenko L., Raimondi S., Wilimas J.A., Jenkins J.J., Davidoff A.M. Regression of a congenital mesoblastic nephroma. Pediatr Blood Cancer 2010;55(2):364-8. doi: 10.1002/pbc.22486.

17. England R.J., Haider N., Vujanic G.M., Kelsey A., Stiller C.A., Pritchard-Jones K., Powis M. Mesoblastic nephroma: a report of the United Kingdom children’s cancer and leukaemia group (CCLG). Pediatr Blood Cancer 2011;56(5):744-8. doi: 10.1002/pbc.22871.

18. Bayindir P., Guillerman R.P., Hicks M.J., Chintagumpala M.M. Cellular mesoblastic nephroma (infantile renal fibrosarcoma): institutional review of the clinical, diagnostic imaging, and pathologic features of a distinctive neoplasm of infancy. Pediatr Radiol 2009;39(10):1066-74. doi: 10.1007/s00247-009-1348-9.